| Application no. and date | 17783857.0 (espacenet) (Federated) (European Patent Register), 20171013 | | Patent/reg. no. and date | DK/EP 3433256, 20190807 | | Publication date | 20190130 | | Priority no. and date | US 201662411799 P, 20161024, US 201662435159 P, 20161216 | | EP pub. no. and date |
EP 3433256 20190130 | | Effective date | | | Applicant/owner | Astrazeneca, AB
151 85 Södertälje, SE | | Applicant ref. no. | 1523835 | | Inventor | NISSINK, Johannes, Wilhelmus, Maria, AstraZeneca
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Canbridgeshire CB4 0WG, GB,
BARLAAM, Bernard, Christophe, AstraZeneca Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
YANG, Bin, AstraZeneca
35 Gatehouse Drive
Waltham, MA 02451, US,
SCOTT, James, Stewart, AstraZeneca Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
MOSS, Thomas, Andrew, AstraZeneca Darwin Building Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
O'DONOVAN, Daniel, Hillebrand, AstraZeneca Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
HUGHES, Samantha, Jayne, AstraZeneca Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/4738 (2006.01) , A61K 31/497 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | | Title | 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINDERIVAT, DER ER ANVENDELIGT TIL BEHANDLING AF CANCER | | Int. application no. | EP2017076191 | | Int. publication no. | WO2018077630 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
